Archive for the ‘Biochimica et Biophysica Acta’ Category
Terry S. Elton, a researcher at Ohio State University in Columbus who studies genetic expression in various heart conditions and Down syndrome, has been sanctioned by the U.S. Office of Research Integrity for fabricating and/or falsifying data in a number of NIH grants and resulting papers.
According to an OSU statement sent to Retraction Watch last night, it was an anonymous whistleblower who alerted the university to the potential misconduct in July 2010. The ORI report notes that he two OSU investigations, along with the ORI investigation, found that Elton: Read the rest of this entry »
Perhaps it’s appropriate given the Easter season, but we have learned that Naoki Mori, the Japanese cancer researcher who received a 10-year publishing ban from the American Society of Microbiology (ASM) for imagine manipulation, has published a new paper.
Mori, who was fired and then rehired by the University of the Ryukyus over the scandal, is listed as the senior author on the paper, “Honokiol induces cell cycle arrest and apoptosis via inhibition of survival signals in adult T-cell leukemia,” which appears in the March issue of Biochimica et Biophysica Acta. The journal, an Elsevier title, is an umbrella for nine publications in the biosciences.
Two of Mori’s retracted articles appeared in the Elsevier journals Leukemia Research and Biochemical and Biophysical Research Communications. Read the rest of this entry »
Bharat B. Aggarwal, the MD Anderson researcher under investigation at his institution over concerns of image manipulation, has withdrawn a second paper, although you’d never know why from the statement.
The notice for the article, “Evidence for the critical roles of NF-κB p65 and specificity proteins in the apoptosis-inducing activity of proteasome inhibitors in leukemia cells,” is pretty minimal: Read the rest of this entry »
Another paper in Diabetologia by Yoshiyuki Hattori has been retracted for image duplication, marking the second of his articles in the journal to be pulled for that reason.
The notice for the article, “A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells,” states: Read the rest of this entry »